For the past 30 years, AFAR has allocated $132 million to 2,800 early-stage scientists researching the fundamental mechanisms of aging as well as how aging underlies the conditions so common in late life: diabetes, heart disease, cancer, dementia, among others.

Why do companies choose AFAR?


       

How can corporations support the science of healthier aging?
Grant-specific donations & sponsorship of symposia, media briefings, website and conferences

Benefits include:

• Named AFAR grant in an area of research of the company's choice.
• Access to top research scientists whose work is ground-breaking in age-related diseases.
• Invitation to all symposia and media briefings concerning the research area.
• Cause-related opportunities around an issue affecting the senior market.
• Media and public relations opportunities.
• Prominent company recognition at AFAR-sponsored events, both online and offline.

A Sample of Our Current and Previous Corporate Partner Programs


For more information, contact Ashby Andrews,
Development Officer, ashby@afar.org, +1 (212) 703-9977